Cauldron Science Limited 07071678 false 2025-01-01 2025-12-31 2025-12-31 The principal activity of the company is that of financial modelling training. Digita Accounts Production Advanced 6.30.9574.0 true 07071678 2025-01-01 2025-12-31 07071678 2025-12-31 07071678 core:FinancialAssetsCostLessImpairment core:Non-currentFinancialInstruments 2025-12-31 07071678 core:CurrentFinancialInstruments 2025-12-31 07071678 core:CurrentFinancialInstruments core:WithinOneYear 2025-12-31 07071678 core:FurnitureFittings 2025-12-31 07071678 core:OfficeEquipment 2025-12-31 07071678 bus:SmallEntities 2025-01-01 2025-12-31 07071678 bus:AuditExemptWithAccountantsReport 2025-01-01 2025-12-31 07071678 bus:FilletedAccounts 2025-01-01 2025-12-31 07071678 bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 07071678 bus:RegisteredOffice 2025-01-01 2025-12-31 07071678 bus:Director2 2025-01-01 2025-12-31 07071678 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 07071678 core:FurnitureFittings 2025-01-01 2025-12-31 07071678 core:OfficeEquipment 2025-01-01 2025-12-31 07071678 countries:EnglandWales 2025-01-01 2025-12-31 07071678 2024-12-31 07071678 core:FurnitureFittings 2024-12-31 07071678 core:OfficeEquipment 2024-12-31 07071678 2024-01-01 2024-12-31 07071678 2024-12-31 07071678 core:CurrentFinancialInstruments 2024-12-31 07071678 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 07071678 core:FurnitureFittings 2024-12-31 07071678 core:OfficeEquipment 2024-12-31 iso4217:GBP xbrli:pure

Registration number: 07071678

Cauldron Science Limited

Annual Report and Unaudited Financial Statements

for the Year Ended 31 December 2025

 

Cauldron Science Limited

Contents

Balance Sheet

1

Notes to the Financial Statements

2 to 5

 

Cauldron Science Limited

(Registration number: 07071678)
Balance Sheet as at 31 December 2025

Note

2025
£

2024
£

Fixed assets

 

Tangible assets

4

15,823

19,373

Other financial assets

5

166,283

106,562

 

182,106

125,935

Current assets

 

Debtors

6

86,530

75,586

Cash at bank and in hand

 

536,962

513,035

 

623,492

588,621

Creditors: Amounts falling due within one year

7

(152,939)

(189,740)

Net current assets

 

470,553

398,881

Net assets

 

652,659

524,816

Capital and reserves

 

Called up share capital

100

100

Retained earnings

652,559

524,716

Shareholders' funds

 

652,659

524,816

For the financial year ending 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

•

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

•

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 23 September 2026 and signed on its behalf by:
 

.........................................
J K H Evershed
Director

 

Cauldron Science Limited

Notes to the Financial Statements for the Year Ended 31 December 2025

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
2 Old Bath Road
Newbury
Berkshire
RG14 1QL
England

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the provision of financial modelling services to customers. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

Foreign currency transactions and balances

Transactions in foreign currencies are initially recorded at the functional currency rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated into the respective functional currency of the entity at the rates prevailing on the reporting period date. Non-monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rate on the date when the fair value is re-measured.

Non-monetary items measured in terms of historical cost in a foreign currency are not retranslated.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

 

Cauldron Science Limited

Notes to the Financial Statements for the Year Ended 31 December 2025

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Office equipment

25% reducing balance basis

Fixtures and fittings

10% reducing balance basis

Investments

Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.

Dividends on equity securities are recognised in income when receivable.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 18 (2024 - 18).

 

Cauldron Science Limited

Notes to the Financial Statements for the Year Ended 31 December 2025

4

Tangible assets

Fixtures and fittings
£

Office equipment
£

Total
£

Cost or valuation

At 1 January 2025

8,582

25,002

33,584

Additions

524

7,773

8,297

Disposals

(3,777)

(18,002)

(21,779)

At 31 December 2025

5,329

14,773

20,102

Depreciation

At 1 January 2025

1,571

12,640

14,211

Charge for the year

727

4,173

4,900

Eliminated on disposal

(1,647)

(13,185)

(14,832)

At 31 December 2025

651

3,628

4,279

Carrying amount

At 31 December 2025

4,678

11,145

15,823

At 31 December 2024

7,011

12,362

19,373

5

Other financial assets (current and non-current)

Financial assets at cost less impairment
£

Total
£

Non-current financial assets

Cost or valuation

At 1 January 2025

106,562

106,562

Revaluations

8,021

8,021

Additions

51,700

51,700

At 31 December 2025

166,283

166,283

Impairment

Carrying amount

At 31 December 2025

166,283

166,283

 

Cauldron Science Limited

Notes to the Financial Statements for the Year Ended 31 December 2025

6

Debtors

Current

2025
£

2024
£

Trade debtors

82,099

69,773

Prepayments

2,316

5,813

Other debtors

2,115

-

 

86,530

75,586

7

Creditors

Creditors: amounts falling due within one year

2025
£

2024
£

Due within one year

Trade creditors

22,133

12,464

Taxation and social security

72,159

70,720

Other creditors

58,647

106,556

152,939

189,740